Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cystic fibrosis
cystic fibrosis
Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation
CP Wire
Thu, 10/11/18 - 09:45 am
Synspira
FDA
SNSP113
cystic fibrosis
Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation
Thu, 10/11/18 - 09:26 am
Synspira
cystic fibrosis
SNSP113
Vivus, diving into the cystic fibrosis sphere, backs stadium step-climbing fundraiser
Fierce Pharma
Thu, 09/27/18 - 11:58 am
Vivus
cystic fibrosis
Pancreaze
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
BioSpace
Fri, 09/7/18 - 11:03 am
Mylan Labs
Novartis
cystic fibrosis
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
CP Wire
Thu, 09/6/18 - 09:35 am
Vertex Pharmaceuticals
VX-659
VX-445
correctors
cystic fibrosis
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Thu, 09/6/18 - 09:20 am
Vertex Pharmaceuticals
VX-659
VX-445
cystic fibrosis
Vertex cystic fibrosis drug gets expanded approval for use in infants
Reuters
Thu, 08/16/18 - 10:18 am
FDA
Vertex Pharmaceuticals
Kalydeco
infants
cystic fibrosis
Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly
Endpoints
Mon, 08/13/18 - 11:18 am
Vertex Pharmaceuticals
NICE
cystic fibrosis
Symkevi
tezacaftor/ivacaftor
Boehringer Ingelheim lands option on cystic fibrosis gene therapy
Fierce Biotech
Mon, 08/6/18 - 09:58 am
Boehringer Ingelheim
cystic fibrosis
Oxford BioMedica
gene therapy
Discovery of unknown lung cell points to new target for cystic fibrosis medicines
Stat
Wed, 08/1/18 - 11:39 pm
cystic fibrosis
drug discovery
drug development
Vertex spars with UK's May over Orkambi pricing
Biopharma Dive
Tue, 07/10/18 - 11:41 am
Vertex Pharmaceuticals
UK
cystic fibrosis
innovation
drug pricing
Orkambi
Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.
Motley Fool
Fri, 06/29/18 - 11:17 am
Galapagos
AbbVie
cystic fibrosis
Vertex Pharmaceuticals
GLPG2737
Vertex doubles size of cystic fibrosis drug discovery site
Fierce Biotech
Tue, 06/19/18 - 10:09 am
Vertex Pharmaceuticals
R&D
drug development
cystic fibrosis
AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient
CP Wire
Thu, 06/7/18 - 09:33 am
Ampliphi Biosciences
cystic fibrosis
MDR pneumonia
AB-PA01
bacteriophage
FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug
Fierce Biotech
Fri, 04/13/18 - 09:42 am
Translate Bio
clinical trials
MRT5005
FDA
cystic fibrosis
Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering
CP Wire
Tue, 03/20/18 - 11:20 pm
Proteostasis Therapeutics
stock offering
PTI-428
cystic fibrosis
clinical trials
Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations
Fierce Pharma
Fri, 02/16/18 - 09:44 am
Vertex Pharmaceuticals
cystic fibrosis
France
Orkambi
New approval helps Vertex's 'cleanest growth story in biotech'
Biopharma Dive
Tue, 02/13/18 - 10:50 pm
Vertex Pharmaceuticals
biotech
cystic fibrosis
Symdeko
Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market
Forbes
Thu, 02/1/18 - 09:32 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
VX-659
VX-445
Galapagos' progress won't rattle CF markets, analysts say
Biopharma Dive
Wed, 01/3/18 - 11:53 pm
Galapagos
cystic fibrosis
GLPG2222
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »